Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuromyelitis Optica Spectrum Disorder (NMOSD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06780709
What this trial is testing

Impact of a Structured Wellness Behavioral Intervention on Quality of Life in NMOSD

Who this might be right for
Neuromyelitis Optica Spectrum Disorder (NMOSD)
Icahn School of Medicine at Mount Sinai 20
Testing effectiveness (Phase 2)WithdrawnNCT06673394
What this trial is testing

Eculizumab For Acute Attack of Neuromyelitis Optica Spectrum Disorder

Who this might be right for
Neuromyelitis Optica Spectrum Disorder Attack
Tianjin Medical University General Hospital
Not applicableLooking for participantsNCT07377305
What this trial is testing

Efficacy and Safety of Transcranial Temporal Interference Stimulation (tTIS) for Neuropathic Pain in Neuromyelitis Optica Spectrum Disorder (NMOSD)

Who this might be right for
NMO Spectrum Disorder
Tang-Du Hospital 12
Not applicableEnrolling By InvitationNCT04886492
What this trial is testing

CorEvitas SPHERES (Synergy of Prospective Health & Experimental Research for Emerging Solutions) Registry for Neuromyelitis Optica Spectrum Disorder (NMOSD)

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
CorEvitas 800
Testing effectiveness (Phase 2)Study completedNCT04614454
What this trial is testing

High Frequency Impulse Therapy for Neuropathic Pain in NMOSD

Who this might be right for
Neuromyelitis Optica
Massachusetts General Hospital 46
Large-scale testing (Phase 3)Study completedNCT04201262
What this trial is testing

An Efficacy and Safety Study of Ravulizumab in Adult Participants With NMOSD

Who this might be right for
Neuromyelitis OpticaNeuromyelitis Optica Spectrum Disorder
Alexion Pharmaceuticals, Inc. 58
Post-approval studies (Phase 4)Study completedNCT05896605
What this trial is testing

Monitoring of Azathioprine Metabolite Concentrations and Cytokine Levels in Neuromyelitis Optica Spectrum Disorder

Who this might be right for
NMO Spectrum DisorderAzathioprine Adverse Reaction
First Affiliated Hospital of Guangxi Medical University 63
Not applicableStudy completedNCT07032337
What this trial is testing

Efficacy and Safety of Conventional Immunosuppressant Therapies in Elderly Patients With Neuromyelitis Optica Spectrum Disorder

Who this might be right for
Neuromyelitis Optica Spectrum Disorder (NMOSD)
Samsung Medical Center 2,985
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07685678
What this trial is testing

Study on Efficacy Evaluation of Ripertamab in the Treatment of Neuromyelitis Optica Spectrum Disorders

Who this might be right for
Neuromyelitis Optica Spectrum Disease (NMOSD)Ripertamab
Zhongming Qiu 20
Not applicableStudy completedNCT03766347
What this trial is testing

Pediatric NMOSD Observational Study

Who this might be right for
Neuromyelitis OpticaNMO Spectrum Disorder
Mayo Clinic 100
Large-scale testing (Phase 3)Ended earlyNCT04155424
What this trial is testing

The Safety and Activity of Eculizumab in Pediatric Participants With Relapsing Neuromyelitis Optica Spectrum Disorder

Who this might be right for
Neuromyelitis OpticaNeuromyelitis Optica Spectrum Disorder
Alexion Pharmaceuticals, Inc. 5
Not applicableEnded earlyNCT07247292
What this trial is testing

Epidemiological Study of Treatment Approaches on AQP4-IgG Positive NMOSD in Russia

Who this might be right for
Rare DiseasesNeuromyelitis Optica Spectrum Disorder (NMOSD)
AstraZeneca 3
Large-scale testing (Phase 3)Study completedNCT02028884
What this trial is testing

Efficacy and Safety Study of Satralizumab (SA237) as Add-on Therapy to Treat Participants With Neuromyelitis Optica (NMO) and NMO Spectrum Disorder (NMOSD)

Who this might be right for
Neuromyelitis Optica (NMO)NMO Spectrum Disorder (NMOSD)
Hoffmann-La Roche 85
Not applicableUnknownNCT05446701
What this trial is testing

Assessment of Serum FAM19A5 Level in Egyptian Patients With Neuromyelitis Optica Spectrum Disorder

Who this might be right for
Assessment of Serum FAM19A5level in Egyptian Patients With NMOSD
Assiut University 120
Testing effectiveness (Phase 2)Study completedNCT05551598
What this trial is testing

Efficacy and Safety of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Neuromyelitis Optica Spectrum Disorder (NMOSD)

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. 46
Large-scale testing (Phase 3)Study completedNCT04660539
What this trial is testing

Evaluate the Safety and Efficacy of Satralizumab in Participants With Neuromyelitis Optica Spectrum Disorder (NMOSD)

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
Hoffmann-La Roche 119
Large-scale testing (Phase 3)Active Not RecruitingNCT05346354
What this trial is testing

Efficacy and Safety Study of Ravulizumab IV in Pediatric Participants With NMOSD

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
Alexion Pharmaceuticals, Inc. 12
Large-scale testing (Phase 3)Active Not RecruitingNCT05403138
What this trial is testing

Safety and Efficacy of Daratumumab in Patients With Anti-Aquaporin 4 Antibody Positive Neuromyelitis Optica Spectrum Disorders

Who this might be right for
Neuromyelitis OpticaNeuromyelitis Optica Spectrum DisorderNMO Spectrum Disorder
Tianjin Medical University General Hospital 135
Not applicableNot Yet RecruitingNCT07304960
What this trial is testing

Multiple Sclerosis Versus Neuromyelitis Optica Spectrum Disorder

Who this might be right for
MS (Multiple Sclerosis)NMO Spectrum Disorder (NMOSD)
Assiut University 100
Testing effectiveness (Phase 2)Ended earlyNCT05356858
What this trial is testing

An Open Label Study of the Effects and Safety of Zanubrutinib in NMOSDs Adult Patients

Who this might be right for
Neuromyelitis Optica
Xuanwu Hospital, Beijing 6
Next Page